Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies
The burden of liver disease in Europe continues to grow. We aimed to describe the
epidemiology of liver diseases and their risk factors in European countries, identifying public …
epidemiology of liver diseases and their risk factors in European countries, identifying public …
Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma
A Shlomai, YP de Jong, CM Rice - Seminars in cancer biology, 2014 - Elsevier
Hepatocellular carcinoma (HCC) is the third leading fatal cancer worldwide and its
incidence continues to increase. Chronic viral hepatitis involving either hepatitis B virus …
incidence continues to increase. Chronic viral hepatitis involving either hepatitis B virus …
[HTML][HTML] The current economic burden of cirrhosis
GW Neff, CW Duncan, ER Schiff - Gastroenterology & hepatology, 2011 - ncbi.nlm.nih.gov
Cirrhosis is a worldwide problem that is associated with a substantial economic burden.
Hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, and alcoholic liver …
Hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, and alcoholic liver …
[HTML][HTML] Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis
Results The polled estimated prevalence of HBV infection in the general population of Iran
was 2.2%(95% CI: 1.9%-2.6%). The highest prevalence of HBV infection (8.9%, 95% CI …
was 2.2%(95% CI: 1.9%-2.6%). The highest prevalence of HBV infection (8.9%, 95% CI …
Recent advances in protective vaccines against hepatitis viruses: A narrative review
Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense
against threats from infectious diseases. The successful history of vaccination is evident in …
against threats from infectious diseases. The successful history of vaccination is evident in …
Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–90) and in the nationwide immunisation …
Background Gambian infants were not routinely vaccinated against hepatitis B virus (HBV)
before 1986. During 1986–90 the Gambia Hepatitis Intervention Study (GHIS) allocated …
before 1986. During 1986–90 the Gambia Hepatitis Intervention Study (GHIS) allocated …
Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy
PK Pratt Jr, N David, HC Weber, FF Little… - Inflammatory bowel …, 2018 - academic.oup.com
Background Studies have demonstrated an association between anti-TNF/
immunomodulator agents used in inflammatory bowel disease (IBD) and impaired hepatitis …
immunomodulator agents used in inflammatory bowel disease (IBD) and impaired hepatitis …
[HTML][HTML] Hepatitis B virus: where do we stand and what is the next step for eradication?
H Komatsu - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Abstract Hepatitis B (HB) virus (HBV) infection, which causes liver cirrhosis and
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …
Prevalence of hepatitis B vaccination coverage and serologic evidence of immunity among US-born children and adolescents from 1999 to 2016
Importance The World Health Assembly has called for the elimination of hepatitis B and C by
2030. As hepatitis B has no cure, the US strategy to eliminate hepatitis B has focused on …
2030. As hepatitis B has no cure, the US strategy to eliminate hepatitis B has focused on …
A scalable synthesis of adjuvanting antigen depots based on metal–organic frameworks
RN Ehrman, OR Brohlin, YH Wijesundara… - Chemical …, 2024 - pubs.rsc.org
Vaccines have saved countless lives by preventing and even irradicating infectious
diseases. Commonly used subunit vaccines comprising one or multiple recombinant …
diseases. Commonly used subunit vaccines comprising one or multiple recombinant …